Cetirizine Hydrochloride Tablet
FDA Label NDC 71335-0300

13 label sections · Submitted to the FDA by Bryant Ranch Prepack · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bryant Ranch Prepack for the product Cetirizine Hydrochloride (NDC 71335-0300). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding purpose, uses:, warnings:, when using this product, if pregnant or breast-feeding:, keep out of reach of children., directions, other information:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Purpose

Antihistamine

Uses:

Temporarily relieves these symptoms due to hay fever or other upper respiratory allergies

  • runny nose
  • sneezing
  • itchy, watery eyes
  • itching of the nose or throat

Warnings:

Do Not Use if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing hydroxyzine.

When Using This Product

  • drowsines may occur
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinary.

If Pregnant Or Breast-Feeding:

  • if breast-feeding: not recommended
  • if pregnant: ask a health professional before use.

Keep Out Of Reach Of Children.

In case of overdose, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Directions

Adults and children 6
years and over
one 10 mg tablet once daily, do not take more than one 10 mg tablet in 24 hours. A 5 mg product may be appropriate for less severe symptoms.
Adults 65 years and overAsk a doctor
Children under 6 years of ageAsk a doctor
Consumers with liver or kidney diseaseAsk a doctor

Other Information:

store at 20° to 25°C (68° to 77°F)

[See USP Controlled Room Temperature].

Inactive Ingredients

Hypromellose, lactose, magnesium stearate, maize starch, polyethylene glycol, povidone, titanium dioxide.

Questions?

Call 1-844-874-7464

Other

Manufactured by:

Unique Pharmaceutical Labs.

(A Div. of J. B. Chemicals & Pharmaceuticals Ltd.),
Mumbai 400 030, India


Distributed by:

Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816

M. L. G/1430    Jul. 2020

126406

How Supplied

NDC: 71335-0300-1: 30 Tablets in a BOTTLE

NDC: 71335-0300-2: 14 Tablets in a BOTTLE

NDC: 71335-0300-3: 7 Tablets in a BOTTLE

NDC: 71335-0300-4: 10 Tablets in a BOTTLE

NDC: 71335-0300-5: 15 Tablets in a BOTTLE

NDC: 71335-0300-6: 90 Tablets in a BOTTLE

NDC: 71335-0300-7: 20 Tablets in a BOTTLE

NDC: 71335-0300-8: 60 Tablets in a BOTTLE

NDC: 71335-0300-9: 100 Tablets in a BOTTLE

Repackaged/Relabeled by:

Bryant Ranch Prepack, Inc.

Burbank, CA 91504

Package Label.Principal Display Panel

Cetirizine Hydrochloride 10 mg Tablet

Label (Lbl713350300)

Label (Lbl713350300)

* Please review the disclaimer below.